We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bowel Preparation for Inpatient Colonoscopy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01169220
Recruitment Status : Completed
First Posted : July 26, 2010
Last Update Posted : October 5, 2017
Sponsor:
Information provided by (Responsible Party):
Santa Clara Valley Health & Hospital System

Brief Summary:
This study will compare two strategies for bowel cleansing prior to inpatient colonoscopy: the entire preparation taken the night before the procedure versus half the preparation taken the night before the procedure, and the other half taken the morning of the procedure.

Condition or disease Intervention/treatment Phase
Gastrointestinal Hemorrhage Colon Cancer Diverticulosis Drug: Go-Lytely Drug: Go Lytely Phase 4

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 55 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Care Provider)
Primary Purpose: Diagnostic
Official Title: Single Blind, Randomized, Controlled Trial of Conventional Versus Split-Dose Bowel Preparation for Inpatient Colonoscopy
Study Start Date : July 2010
Primary Completion Date : January 2014
Study Completion Date : January 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Colonoscopy
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Split prep Drug: Go Lytely
Bowel cleansing agent
Active Comparator: Whole prep Drug: Go-Lytely
Bowel cleansing agent



Primary Outcome Measures :
  1. Quality of colon cleansing [ Time Frame: 24 hours from study enrollment ]

Secondary Outcome Measures :
  1. Patient satisfaction [ Time Frame: 24 hours from study enrollment ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • any diagnosis for which colonoscopy is indicated

Exclusion Criteria:

  • ileus
  • severe colitis/toxic megacolon
  • gastric retention
  • bowel perforation
  • gastrointestinal obstruction
  • gastroparesis that precludes oral bowel preparation
  • pregnant or lactating women
  • allergy to polyethylene glycol.
  • unable to give consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01169220


Locations
United States, California
Santa Clara Valley Medical Center
San Jose, California, United States, 95128
Sponsors and Collaborators
Santa Clara Valley Health & Hospital System

Responsible Party: Santa Clara Valley Health & Hospital System
ClinicalTrials.gov Identifier: NCT01169220     History of Changes
Other Study ID Numbers: 10-041
First Posted: July 26, 2010    Key Record Dates
Last Update Posted: October 5, 2017
Last Verified: October 2017

Keywords provided by Santa Clara Valley Health & Hospital System:
Colonoscopy
Bowel preparation

Additional relevant MeSH terms:
Hemorrhage
Gastrointestinal Hemorrhage
Diverticulum
Pathologic Processes
Gastrointestinal Diseases
Digestive System Diseases
Pathological Conditions, Anatomical